Amneal Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,019	2,794	2,394	2,212	2,094
Revenue Growth (YoY)	8.05%	16.73%	8.20%	5.67%	5.08%
Cost of Revenue	1,905	1,774	1,573	1,428	1,325
Gross Profit	1,113	1,020	820.57	784.71	768.97
Selling, General & Admin	526.83	476.44	429.68	399.7	365.5
Research & Development	193.81	196.56	198.58	213.02	210.27
Other Operating Expenses	-1.42	98.12	-12.06	266.92	40.48
Total Operating Expenses	719.21	771.11	616.19	879.64	616.26
Operating Income	394.1	249.33	204.37	-94.93	152.72
Interest Expense	-241.09	-258.6	-210.63	-158.38	-136.33
Other Non-Operating Income (Expense)	-13.8	-45.74	-34.02	5.18	14.98
Total Non-Operating Income (Expense)	-254.89	-304.34	-244.64	-153.2	-121.35
Pretax Income	139.21	-55.01	-40.27	-248.13	31.37
Provision for Income Taxes	11.28	18.86	8.45	6.66	11.2
Net Income	72.06	-116.89	-83.99	-129.99	10.62
Minority Interest in Earnings	55.88	43.01	35.27	-124.8	9.55
Net Income to Common	72.06	-116.89	-83.99	-129.99	10.62
Net Income Growth	-	-	-	-	-88.33%
Shares Outstanding (Basic)	313	309	176	151	152
Shares Outstanding (Diluted)	325	309	176	151	152
Shares Change (YoY)	5.12%	75.42%	16.53%	-0.41%	1.67%
EPS (Basic)	0.23	-0.38	-0.48	-0.86	0.07
EPS (Diluted)	0.22	-0.38	-0.48	-0.86	0.07
EPS Growth	-	-	-	-	-88.52%
Shares Outstanding	314.57	309.88	306.57	151.49	149.41
Free Cash Flow	241.15	234.76	298.78	16.31	190.88
Free Cash Flow Growth	2.72%	-21.43%	1732.42%	-91.46%	-39.82%
Free Cash Flow Per Share	0.74	0.76	1.70	0.11	1.26
Gross Margin	36.88%	36.52%	34.28%	35.47%	36.73%
Operating Margin	13.05%	8.92%	8.54%	-4.29%	7.29%
Profit Margin	4.24%	-2.64%	-2.04%	-11.52%	0.96%
FCF Margin	7.99%	8.40%	12.48%	0.74%	9.12%
EBITDA	617.67	485.52	433.77	145.25	386.12
EBITDA Margin	20.46%	17.38%	18.12%	6.57%	18.44%
EBIT	394.1	249.33	204.37	-94.93	152.72
EBIT Margin	13.05%	8.92%	8.54%	-4.29%	7.29%
Effective Tax Rate	8.10%	-34.29%	-20.99%	-2.68%	35.69%

Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q